Company Description
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services.
It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services.
In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med.
Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services.
Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.
| Country | United States |
| Founded | 1999 |
| Industry | Integrated Freight & Logistics |
| Sector | Industrials |
| Employees | 1,019 |
| CEO | Jerrell W. Shelton |
Contact Details
Address: 112 Westwood Place, Suite 350 Brentwood, Tennessee 37027 United States | |
| Phone | (949) 232-1900 |
| Website | cryoport.com |
Stock Details
| Ticker Symbol | CYRX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001124524 |
| CUSIP Number | 229050307 |
| ISIN Number | US2290503075 |
| Employer ID | 88-0313393 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jerrell W. Shelton | Chairman, President and Chief Executive Officer |
| Robert S. Stefanovich MS | Chief Financial Officer and Treasurer |
| Edward J. Zecchini | Senior Vice President and Chief Digital and Technology Officer |
| Dr. Mark W. Sawicki Ph.D. | Chief Scientific Officer |
| Thomas J. Heinzen | Vice President of Corporate Development and Investor Relations |
| Tony Ippolito | Vice President, General Counsel and Corporate Secretary |
| Kylie A. Crowe | Vice President of Global Human Resources and Organizational Development |
| Bret Bollinger | Vice President and Chief Innovation Officer |
| Phil Wilson | Chief Operating Officer of Cryoport Systems, LLC |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 3, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 3, 2024 | DEF 14A | Other definitive proxy statements |
| Mar 15, 2024 | 144 | Filing |
| Mar 13, 2024 | 10-K | Annual Report |
| Mar 12, 2024 | 8-K | Current Report |
| Feb 15, 2024 | 8-K | Current Report |
| Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Feb 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |